Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nina S. Mathew
Institution:
University of Kansas Medical Center
Observed institution:
University of Kansas Medical Center
ORCID:
0009-0004-6403-5621
Observed ORCID:
0009-0004-6403-5621
OpenAlex ID:
A5137099968
Circulating Tumor DNA (ctDNA) Clearance After Immune Checkpoint Inhibition (ICI) with Radiotherapy (RT) as a Prognostic Biomarker for Advanced Melanoma
2026
·
Alyssa K. Steimle
, Amir M. Forati
, et al.
·
Cancers
Circulating tumor DNA (ctDNA) clearance after immune checkpoint inhibition (ICI) with radiotherapy (RT) as a prognostic indicator for patients with advanced melanoma.
2026
·
Alyssa K. Steimle
, Amir W. Forati
, et al.
·
Journal of Clinical Oncology
Optimal timing of circulating tumor DNA (ctDNA) dynamics to prognosticate immune checkpoint inhibitors (ICI) efficacy in patients with advanced stage melanoma.
2026
·
Vincent T. Ma
, Amir W. Forati
, et al.
·
Journal of Clinical Oncology
Prognostic significance of ctDNA detection at the time of relapse during melanoma surveillance.
2026
·
Soham Ali
, Amir W. Forati
, et al.
·
Journal of Clinical Oncology
A late-phase randomized open-label multi-cohort trial to evaluate immune-related adverse events with different standard-of-care dosing strategies of standard-of-care immunotherapies: ImmuRAd trial.
2026
·
Anup Kasi
, Anusha Chidharla
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
5
Citation count:
H-index:
I10-index:
Year
Topic
Type